TR200900878A2 - Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar - Google Patents

Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar

Info

Publication number
TR200900878A2
TR200900878A2 TR2009/00878A TR200900878A TR200900878A2 TR 200900878 A2 TR200900878 A2 TR 200900878A2 TR 2009/00878 A TR2009/00878 A TR 2009/00878A TR 200900878 A TR200900878 A TR 200900878A TR 200900878 A2 TR200900878 A2 TR 200900878A2
Authority
TR
Turkey
Prior art keywords
dosage form
single dosage
pharmaceutical formulations
formulations combined
combined
Prior art date
Application number
TR2009/00878A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/00878A priority Critical patent/TR200900878A2/tr
Priority to PCT/TR2010/000026 priority patent/WO2010090614A1/en
Publication of TR200900878A2 publication Critical patent/TR200900878A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Abstract

Mevcut buluş, aktif maddelerin hastanın tedaviye uyumunu ve dolayısıyla tedavinin başarısını artırmak üzere tek bir dozaj formunda kombine edildiği stabil farmasötik bileşimlere ilişkindir.
TR2009/00878A 2009-02-05 2009-02-05 Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar TR200900878A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/00878A TR200900878A2 (tr) 2009-02-05 2009-02-05 Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
PCT/TR2010/000026 WO2010090614A1 (en) 2009-02-05 2010-02-02 Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/00878A TR200900878A2 (tr) 2009-02-05 2009-02-05 Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar

Publications (1)

Publication Number Publication Date
TR200900878A2 true TR200900878A2 (tr) 2010-08-23

Family

ID=42035957

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/00878A TR200900878A2 (tr) 2009-02-05 2009-02-05 Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar

Country Status (2)

Country Link
TR (1) TR200900878A2 (tr)
WO (1) WO2010090614A1 (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2661262B1 (en) * 2011-01-06 2017-11-15 Mahmut Bilgic Improved bisphosphonate formulations
TR201100149A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Geliştirilmiş risedronat formülasyonu.
MX350569B (es) * 2012-12-03 2017-09-11 Landsteiner Scient S A De C V Composicion farmaceutica estable para el tratamiento de osteoporosis.
WO2014122658A1 (en) * 2013-02-11 2014-08-14 Amorphical Ltd. Amorphous calcium carbonate for accelerated bone growth
CR20160395A (es) 2014-02-13 2016-12-20 Incyte Corp Ciclopropilaminas como inhibidores de lsd1
KR102421235B1 (ko) 2014-02-13 2022-07-15 인사이트 코포레이션 Lsd1 저해제로서 사이클로프로필아민
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
EP3277689B1 (en) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
BR112018002553A8 (pt) 2015-08-12 2023-01-24 Incyte Corp Sais de um inibidor de lsd1
IT201700099708A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio
CN107897934A (zh) * 2017-11-16 2018-04-13 广州市健鸣春生物科技有限公司 预防胎儿先天疾病、预防流产的复合维生素矿物质片及其制备方法
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE69233250T2 (de) 1991-05-06 2004-08-26 The Procter & Gamble Company, Cincinnati Kombinationen aus calzium und vitamin d
DE19710054A1 (de) 1997-03-12 1998-09-17 Merck Patent Gmbh Pharmazeutische Zubereitung
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
EP1494683A1 (en) 2002-04-05 2005-01-12 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US7259143B2 (en) 2002-09-05 2007-08-21 Wisconsin Alumni Research Foundation Method of extending the dose range of vitamin D compounds
ITFI20030194A1 (it) 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
RU2326695C2 (ru) 2003-09-19 2008-06-20 Пфайзер Продактс Инк. Фармацевтические композиции и способы, включающие комбинации 2-алкилиденовых производных 9-нор-витамина d и бисфосфоната
US20050261250A1 (en) 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
US7645459B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
ES2255429B1 (es) * 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
JP2009508834A (ja) * 2005-09-16 2009-03-05 セラマイン リミテッド ビスホスホネート製剤
US20110039804A1 (en) 2006-12-20 2011-02-17 Landsteiner Scientific, S.A. De C.V. Composition of Risedronate and Vitamin D3

Also Published As

Publication number Publication date
WO2010090614A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
TR200900878A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
MD4577B1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
CU23923B1 (es) Polipéptidos derivados de la il-2 con actividad agonista
MX2010009851A (es) Oblea gingival.
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
MX2019003467A (es) Formulaciones y metodos para la administracion vaginal de antiprogestinas.
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
IN2012DN06720A (tr)
MY161595A (en) Oral care compositions
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
ECSP045029A (es) Composiciones de valdecoxib de disgregación intraoral
TN2015000135A1 (en) Modified release formulations for oprozomib
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
TR200908237A2 (tr) Kalsiyum ve D vitamini içeren farmasötik bileşimler.
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
TR200900881A2 (tr) Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900880A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR201005327A2 (tr) Sinerjik farmasötik formülasyonlar.
EA201291420A1 (ru) Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли
EA201170950A1 (ru) Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида